1985
DOI: 10.1083/jcb.100.3.684
|View full text |Cite
|
Sign up to set email alerts
|

Immunochemical demonstration that amino acids 360-377 of the acetylcholine receptor gamma-subunit are cytoplasmic.

Abstract: TWO monoctonal antibodies (mabs) previously prepared against Torpedo acetylcholine receptor are shown to recognize a synthetic nonadecapeptide corresponding to lys360-glu377 of the gamma subunit. The reaction was demonstrated by solid-phase enzyme-linked immunoabsorbent assays, by inhibition of binding of the mabs to receptor, and by immunoprecipitation of the peptide conjugated to bovine serum albumin. Immunogold electron microscopy on isolated postsynaptic membranes from Torpedo showed that both mabs bind to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
26
0
1

Year Published

1985
1985
2003
2003

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(30 citation statements)
references
References 43 publications
3
26
0
1
Order By: Relevance
“…The peptides were synthesised in accordance with standard methodology (Atherton and Sheppard 1985) and were composed of the following amino acid residues: Kir2.1: (C)HNQASVPLEPRPL (residues 409-421), Kir2.2: (C)RLQASSGALERPY (residues 409-421) and Kir2.3: (C)RMQAATLPLDNISY (residues 427-440). N-terminal cysteine residues were added to the peptides to facilitate conjugation to ovalbumin carrier protein (Larochelle et al 1985) and were not part of the channel protein sequences. The peptideovalbumin conjugates were inoculated into New Zealand White rabbits.…”
Section: Preparation Of Polyclonal Antibodiesmentioning
confidence: 99%
“…The peptides were synthesised in accordance with standard methodology (Atherton and Sheppard 1985) and were composed of the following amino acid residues: Kir2.1: (C)HNQASVPLEPRPL (residues 409-421), Kir2.2: (C)RLQASSGALERPY (residues 409-421) and Kir2.3: (C)RMQAATLPLDNISY (residues 427-440). N-terminal cysteine residues were added to the peptides to facilitate conjugation to ovalbumin carrier protein (Larochelle et al 1985) and were not part of the channel protein sequences. The peptideovalbumin conjugates were inoculated into New Zealand White rabbits.…”
Section: Preparation Of Polyclonal Antibodiesmentioning
confidence: 99%
“…in [21]). The sequence 7360-377 has been directly shown by Ab binding to be on the cytoplasmic surface ofthe TAChR [22]. Insufficient information on the TAChR structure is available at this point to allow firm conclusions as to whether the other TAChR sequences found to form 'cryptic epitopes' are or are not exposed on the TAChR surface.…”
Section: Introductionmentioning
confidence: 99%
“…Peptides were synthesized according to Atherton and Sheppard 15 and were composed of the following amino acid residues: Kir6.1; (C)KVQFMTPEGNQCPSES (residues 409-424, Protein and Nucleic Acid Chemistry Laboratory, University of Leicester, UK), Kir6.2; (C)KAKPKFSISPDSLS (residues 377-390, Research Genetics Inc. Huntsville, USA), SUR2A; PNLLQHKNGLFSTLVMTNK(C) (residues 1527-1545, Pepceuticals Ltd., Leicester, UK), SUR2B; ESLLAQEDGVFASFVRADM(C) (residues 1528-1546, Pepceuticals Ltd) 15 . N-or C-terminal cysteine residues were added to the peptides to facilitate conjugation 16 to ovalbumin (Kir6.1) or Keyhole Limpet Haemocyanin carrier protein and were not part of the channel subunit sequences. Antisera were raised against peptide carrier protein conjugates in New Zealand White Rabbits (Kir6.1, University of Leicester; Kir6.2, Research Genetics Inc.; SUR2A and SUR2B, Pepceuticals Ltd.).…”
Section: Preparation Of Polyclonal Antibodiesmentioning
confidence: 99%